Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Drugs Conserved-yeast-nucleic-acid-sequences

 Platelet aggregation inhibitors
We claim: 1. A method of treating or preventing a platelet associated ischemic disorder in a ...


 Adhesion receptor antagonists
What is claimed is: 1. An oxazolidinone compound of formula I ##STR10## wherein R.sup.1 is ##STR11##...


 Activation of peptide prodrugs by hK2
What is claimed is: 1. A composition comprising a prodrug, the prodrug comprising a therapeutically ...


 Device having diarrhea diagnostic panel
The present invention is directed to a device that comprises a sensor adapted to detect one or more ...


 Method for the treatment of chemonucleolysis
A method of this invention involves a treatment comprising administering to a mammal in need of ...


 Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
The present invention provides such monoclonal antibodies, HB22, which identify a region of the CD22...


 PRO1312 polypeptides
1. PR0281 A cDNA clone (DNA16422-1209) has been identified, having homology to nucleic acid ...


 Purified p75 (type II) tumor necrosis factor receptor polypeptides
The present invention provides isolated TNF receptors and DNA sequences encoding mammalian tumor ...


 Derivatives of choline binding proteins for vaccines
OF THE INVENTION In accordance with an aspect of the present invention there is provided a vaccine ...


 Pneumococcal protein homologs and fragments for vaccines
OF THE INVENTION The present invention is directed to novel polynucleotides and polypeptides ...


 Conserved yeast nucleic acid sequences

Details
Inventors: Hoyer, Lois L.; Livi, George P.; Shatzman, Allan R.;
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Primary Examiner: Jonex; W. Garin
Assistant Examiner: Whisenant; Ethan
Attorney, Agent or Firm: Gimmi; Edward R., King; William T., Lentz; Edward T.

This invention relates to nucleic acid sequences conserved in strains of yeasts. More particularly, this invention relates to segments of the ALS1 gene of Candida albicans useful as probes and primers for the identification of yeast, particularly Candida, infections.

DETAILED DESCRIPTION OF THE INVENTION The present invention advantageously provides both probes and primers which bind to a variety of strains of C.
albicans and C.
stellatoidea.
General probes are useful as an initial screen for Candidal infection, and provide a rapid alternative to the culturing techniques currently employed as an initial screen, which require on the order of days to weeks of culturing.
Once a positive result on the initial screen is found, the species specific probes can be employed, if necessary, to provide a rapid means to diagnose the particular infection.
Nucleotide sequences are presented herein by single strand only, in the 5' to 3' direction, from left to right.
One letter nucleotide symbols used herein have their standard meaning in the art in accordance with the recommendations of the IUPAC-IUB Biochemical Nomenclature Commission and the Patent Office Rules.
The term "Candida" as used herein has its conventional meaning in the art (See generally B.
Davis et al.
, Microbiology, 995-96 (2d Ed.
1973).
By way of example, the Candida include, but are not limited to, C.
albicans, C.
claussenii, C.
langeronii, C.
stellatoidea, C.
glabrata, C.
gulliermondi, C.
keyfr, C.
krusei, C.
lusitaniae, C.
parapsilosis.
C.
tropicalis and C.
viswanathii.
The term "amplification pair," as used herein, refers to a pair of oligonucleotide probes of the present invention selected to be suitable for use together in amplifying a selected Candida nucleic acid sequence by a process such as polymerase chain reaction, ligase chain reaction, or strand displacement amplification, as explained in greater detail below.
Nucleic acid (i.
e.
, DNA or RNA) samples for practicing the present invention may be obtained from any suitable source.
Typically, the nucleic acid sample will be obtained in the form of a sample of a biological fluid or biological tissue suspected of containing Candida.
Suitable biological fluids include, but are not limited to, sputum, bronchial washings, gastric washings (containing swallowed sputum), blood, milk, and lymph fluid



Related patents
  Compositions and methods for the therapy and diagnosis of prostate cancer
Briefly stated, the present invention provides compositions and methods for the diagnosis and therapy of cancer, such as prostate cancer. In one aspect, the present ...
  Compositions structured with at least one polymer and methods of using the same
What is claimed is: 1. A structured cosmetic composition comprising: (i) at least one continuous liquid fatty phase, wherein said at least one continuous liquid fatty ...
  Synthetic peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
OF THE INVENTION The invention provides for peptides derived from a neutrophil bacterial permeability protein (B/PI). The peptides are those that are biologically ...
  Therapeutic uses of bactericidal/permeability-increasing protein dimer products
The present invention provides significant improvements in therapeutic uses of BPI protein products through the provision of product formulations which include BPI ...
  Synthesis of soluble .beta.-sheet forming peptides
OF THE INVENTION An intricate interplay exists between peptide .beta.-sheet formation, self-association, and water solubility. A challenge in making a soluble folded ...
  Flavivirus antigen
What is claimed is: 1. An antigen consisting essentially of an amino acid sequence represented by the following formula (I): Phe Asn Cys Leu Gly Met Gly Asn Arg Asp Phe I...
  Poxvirus containing formulations and process for preparing stable poxvirus containing compositions
OF THE INVENTION The present invention provides poxvirus containing formulation, in particular an aqueous poxvirus containing formulation. The formulation, in ...
  Screening method for orthopoxvirus antivirals
What is claimed is: 1. An assay comprising the steps of: infecting cultured cells with vaccinia virus; co-transfecting the cells with one or more plasmids comprising DNA ...
  Fibrinogen receptor antagonists
OF THE INVENTION Compounds of the invention are fibrinogen receptor antagonists which inhibit fibrinogen induced platelet aggregation. These compounds are prepared by ...
  Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
We claim: 1. A cyclopeptide compound of formula I cyclo-(Arg-B-Asp-D-E) I, wherein: B is Gly, Ala, or--HN--Q--CO--; D is Phe, 4-Hal-Phe, Nal, or Phig; E is Gly, Ala, Lys,...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved